In January 2006, GeneOhm was acquired by Becton, Dickinson & Co. In October 2004, GeneOhm had merged with Canadian firm Infectio Diagnostic. GeneOhm Sciences uses the flow of electric current through DNA to detect genetic mutations. This proprietary chip-based technology allows clinicians to identify a patient's mutations accurately, sensitively and rapidly with a simple and inexpensive reader. GeneOhm was formed with technology developed over a decade by Professor Jacqueline K. Barton at the California Institute of Technology. The Company believes its platform will become the primary system that clinicians use to focus human genomic information on individual patient care.
